Company

Cingulate Therapeutics, LLC (CTx) is a privately held biopharmaceutical company focused on the development of new products for the treatment of central nervous system and neurobiological disorders.

Explore

Pipeline

Cingulate Therapeutics currently has two (2) products in pre-clinical development for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Explore

The Cingulate Solution

  • Triphasic Controlled-Release:
    • Combines Immediate, Sustained and Delayed Release
    • Designed to deliver a rapid onset and last the entire active day while minimizing the afternoon crash and impact on sleep and appetite
Explore
Cingulate-Solution